Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001539497-22-000183
Filing Date
2022-01-28
Accepted
2022-01-28 14:15:55
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 4614
  Complete submission text file 0001539497-22-000183.txt   6293
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 RUE ARISTIDE MAILLOL PARIS I0 75015
Business Address
Chen-Walden Hana (Reporting) CIK: 0001907211 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35027 | Film No.: 22567649